Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer. [electronic resource]
Producer: 20201113Description: 98-108 p. digitalISSN:- 1543-8392
- Albumins
- Antibodies, Monoclonal -- chemistry
- Antigens, Surface -- immunology
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Cell Line, Tumor
- Cell Survival -- drug effects
- Click Chemistry -- methods
- Cyclooctanes -- chemistry
- Drug Delivery Systems -- methods
- Fluorobenzenes -- chemistry
- Glutamate Carboxypeptidase II -- immunology
- Humans
- Immunoglobulin Fab Fragments -- chemistry
- Male
- Maytansine -- therapeutic use
- Nanomedicine
- Prostatic Neoplasms -- drug therapy
- Tubulin Modulators -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.